The addition of H. Reisman’s natural carotenoid product range provides synergy and expands LycoRed’s position in the market. H. Reisman has extensive experience in added value carotenoid formulations and manufacturing, and provides LycoRed with a U.S. manufacturing base.
"LycoRed, with its acquisition of H. Reisman, will be able to provide a complete service package; offering a wider product range, and the extensive analytical and formulation capabilities of LycoRed's other companies," said Morris Zelkha, president and CEO, LycoRed Ltd. “This is part of an industry-wide consolidation towards single suppliers of multiple value-added ingredients and services, and LycoRed is much attuned to the needs of our customers.”
Pharmachem Laboratories and LycoRed have been successful business partners for the last decade. LycoRed and Pharmachem Laboratories will continue to work in close cooperation after the acquisition of H. Reisman and continue to be the sales arm for LycoRed carotenoid beadlet products.
Michael Reuben, current vice president and general manager of H. Reisman, will continue with the new organization to ensure smooth transition and integration with LycoRed.
This new acquisition will be part of the newly formed LycoRed Corp., which was created in November 2005 with LycoRed’s acquisition of Buckton Scott Nutrition and managed by Leo Cullen.